These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35459796)

  • 1. How can we interpret the relationship between liquid-liquid phase separation and amyotrophic lateral sclerosis?
    Kanekura K; Kuroda M
    Lab Invest; 2022 Sep; 102(9):912-918. PubMed ID: 35459796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
    Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
    Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aberrant fused in sarcoma liquid droplet of amyotrophic lateral sclerosis pathological variant, R495X, accelerates liquid-solid phase transition.
    Shiramasa Y; Yamamoto R; Kashiwagi N; Sasaki F; Imai S; Ike M; Kitazawa S; Kameda T; Kitahara R
    Sci Rep; 2024 Apr; 14(1):8914. PubMed ID: 38632300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism underlying liquid-to-solid phase transition in fused in sarcoma liquid droplets.
    Li S; Yoshizawa T; Shiramasa Y; Kanamaru M; Ide F; Kitamura K; Kashiwagi N; Sasahara N; Kitazawa S; Kitahara R
    Phys Chem Chem Phys; 2022 Aug; 24(32):19346-19353. PubMed ID: 35943083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
    Kalmar B; Lu CH; Greensmith L
    Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.
    Pakravan D; Orlando G; Bercier V; Van Den Bosch L
    J Mol Cell Biol; 2021 Apr; 13(1):15-28. PubMed ID: 32976566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALS-linked FUS mutations dysregulate G-quadruplex-dependent liquid-liquid phase separation and liquid-to-solid transition.
    Ishiguro A; Lu J; Ozawa D; Nagai Y; Ishihama A
    J Biol Chem; 2021 Nov; 297(5):101284. PubMed ID: 34624313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP enhances at low concentrations but dissolves at high concentrations liquid-liquid phase separation (LLPS) of ALS/FTD-causing FUS.
    Kang J; Lim L; Song J
    Biochem Biophys Res Commun; 2018 Oct; 504(2):545-551. PubMed ID: 30205960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular Pathogenesis of Amyotrophic Lateral Sclerosis].
    Tsuboguchi S; Ishihara T; Sugai A; Yokoseki A; Onodera O
    Brain Nerve; 2019 Nov; 71(11):1183-1189. PubMed ID: 31722304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues.
    Li HR; Chiang WC; Chou PC; Wang WJ; Huang JR
    J Biol Chem; 2018 Apr; 293(16):6090-6098. PubMed ID: 29511089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.
    Mackenzie IR; Nicholson AM; Sarkar M; Messing J; Purice MD; Pottier C; Annu K; Baker M; Perkerson RB; Kurti A; Matchett BJ; Mittag T; Temirov J; Hsiung GR; Krieger C; Murray ME; Kato M; Fryer JD; Petrucelli L; Zinman L; Weintraub S; Mesulam M; Keith J; Zivkovic SA; Hirsch-Reinshagen V; Roos RP; Züchner S; Graff-Radford NR; Petersen RC; Caselli RJ; Wszolek ZK; Finger E; Lippa C; Lacomis D; Stewart H; Dickson DW; Kim HJ; Rogaeva E; Bigio E; Boylan KB; Taylor JP; Rademakers R
    Neuron; 2017 Aug; 95(4):808-816.e9. PubMed ID: 28817800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid-to-solid phase transition of Cu/Zn superoxide dismutase 1 initiated by oxidation and disease mutation.
    Gu S; Xu M; Chen L; Shi X; Luo SZ
    J Biol Chem; 2023 Feb; 299(2):102857. PubMed ID: 36592929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FUS and TDP-43 Phases in Health and Disease.
    Portz B; Lee BL; Shorter J
    Trends Biochem Sci; 2021 Jul; 46(7):550-563. PubMed ID: 33446423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
    Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
    Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misfolded SOD1 inclusions in patients with mutations in
    Forsberg K; Graffmo K; Pakkenberg B; Weber M; Nielsen M; Marklund S; Brännström T; Andersen PM
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):861-869. PubMed ID: 30992335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of ALS and FTD: implications for translational studies.
    Liščić RM
    Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
    Wang XN; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.